Kimon Angelides– EIR’s


  • Kimon Angelides is the founder of four healthcare companies: Vivante, EsoHealth which became Livongo and debuted in July 2019 with a $355M IPO at a $4.4B valuation, DiabetesAmerica, a network of diabetes centers that pioneered bundled payment models, and mAbGen, a cancer biotech company that partnered with world-renowned MDAnderson Cancer Center and was acquired by Valeant Pharmaceuticals.
  • Kimon recently received the digital health Founder of the Year Award from Rock Health, Goldman Sachs, and PacWest Bank for his contributions and work in digital medicine. Kimon’s newest company, Vivante Health, was created in early 2016 to tackle the needs of people who have invisible and stigmatized diseases, starting with digestive health and are those who have fallen through the cracks in the healthcare system. The company takes a multidisciplinary approach using digital therapeutics, diagnostics and discovery medicine, devices, and predictive analytics, all taken to enhance outcomes.
  • Prior to his healthcare career, Kimon was Director of Strategic Development at St Luke’s/Texas Heart Institute, Professor and Chair of Cell Biology and Biomedical Sciences at the University of Durham in the UK building the pre-clinical services for the new medical school, Professor of Cell Biology, Neuroscience, Biochemistry, and Molecular Biophysics at Baylor College of Medicine, and Associate and Assistant Professor at the University of Florida and McGill University. Kimon has served on the National Medical Advisory Boards of the National Multiple Sclerosis Society, Muscular Dystrophy Association, and the National Institutes of Health. Kimon was Research Career Development Award from the NIH, a Mombusho Scholar of Japan, Distinguished Professor at INSERM/Centre National de Recherche Scientifique of France, and a Basil O’Connor Scholar from the March of Dimes Birth Defect Foundation. He has published over 100 papers and holds more than 40 patents. He received a PhD in Chemistry from the University of California and has done graduate study in business, laws, and public health.